Status:
UNKNOWN
Comparison of Triggers in Double Ovarian Stimulation (DuoStim).
Lead Sponsor:
Instituto Bernabeu
Conditions:
IVF
LOW OVARIAN RESPONSE
Eligibility:
FEMALE
28-43 years
Phase:
PHASE4
Brief Summary
This study aims to investigate the efficacy of 3 different trigggers used for final maturation in the second ovarian stimulation in double stimulation protocol (aGnRH and hCG-rec vs. aGnRH only vs. hC...
Eligibility Criteria
Inclusion
- BMI below 32
- Presence of both ovaries
- Indication for ovarian stimulation under Double Stimulation protocol (Duo Stim)
- Meeting the criteria for Duo Stim
- Medical history, history and physical examination without alterations
- AMH and AFV results in accordnace to Poseidon classification group 3 or 4 no more than 6 months prior to signing the consent form
- Ability to participate and comply with the study protocol.
- To have given written consent
- Normal karyotype and fragile X.
Exclusion
- Non-compliance with instructions and/or non-formalization of consents or legal requirements for IVF.
- Concurrent participation in another study
Key Trial Info
Start Date :
March 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT05321511
Start Date
March 3 2022
End Date
March 31 2023
Last Update
April 11 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Bernabeu
Palma de Mallorca, Mallorca, Spain, 07006
2
Instituto Bernabeu
Albacete, Spain, 02005
3
Instituto Bernabeu
Alicante, Spain, 03016
4
Instituto Bernabeu
Madrid, Spain, 28001